Literature DB >> 28986452

Care in Specialized Centers and Data Sharing Increase Agreement in Hypertrophic Cardiomyopathy Genetic Test Interpretation.

Aisha Furqan1, Patricia Arscott1, Francesca Girolami1, Allison L Cirino1, Michelle Michels1, Sharlene M Day1, Iacopo Olivotto1, Carolyn Y Ho1, Euan Ashley1, Eric M Green1, Colleen Caleshu2.   

Abstract

BACKGROUND: Clinically impactful differences in the interpretation of genetic test results occur between laboratories and clinicians. To improve the classification of variants, a better understanding of why discrepancies occur and how they can be reduced is needed. METHODS AND
RESULTS: We examined the frequency, causes, and resolution of discordant variant classifications in the Sarcomeric Human Cardiomyopathy Registry (SHaRe), a consortium of international centers with expertise in the clinical management and genetic architecture of hypertrophic cardiomyopathy. Of the 112 variants present in patients at >1 center, 23 had discordant classifications among centers (20.5%; Fleiss κ, 0.54). Discordance was more than twice as frequent among clinical laboratories in ClinVar, a public archive of variant classifications (315/695 variants; 45.2%; Fleiss κ, 0.30; P<0.001). Discordance in SHaRe most frequently occurred because hypertrophic cardiomyopathy centers had access to different privately held data when making their classifications (75.0%). Centers reassessed their classifications based on a comprehensive and current data summary, leading to reclassifications that reduced the discordance rate from 20.5% to 10.7%. Different interpretations of rarity and co-occurrence with pathogenic variants contributed to residual discordance.
CONCLUSIONS: Discordance in variant classification among hypertrophic cardiomyopathy centers is largely attributable to privately held data. Some discrepancies are caused by differences in expert assessment of conflicting data. Discordance was markedly lower among centers specialized in hypertrophic cardiomyopathy than among clinical laboratories, suggesting that optimal genetic test interpretation occurs in the context of clinical care delivered by specialized centers with both clinical and genetics expertise.
© 2017 American Heart Association, Inc.

Entities:  

Keywords:  cardiomyopathy, hypertrophic; genetic counseling; genetic testing; registries

Mesh:

Year:  2017        PMID: 28986452     DOI: 10.1161/CIRCGENETICS.116.001700

Source DB:  PubMed          Journal:  Circ Cardiovasc Genet        ISSN: 1942-3268


  12 in total

1.  Role of genetic heart disease in sentinel sudden cardiac arrest survivors across the age spectrum.

Authors:  John R Giudicessi; Michael J Ackerman
Journal:  Int J Cardiol       Date:  2018-05-30       Impact factor: 4.164

2.  Variant Classification Concordance using the ACMG-AMP Variant Interpretation Guidelines across Nine Genomic Implementation Research Studies.

Authors:  Laura M Amendola; Kathleen Muenzen; Leslie G Biesecker; Kevin M Bowling; Greg M Cooper; Michael O Dorschner; Catherine Driscoll; Ann Katherine M Foreman; Katie Golden-Grant; John M Greally; Lucia Hindorff; Dona Kanavy; Vaidehi Jobanputra; Jennifer J Johnston; Eimear E Kenny; Shannon McNulty; Priyanka Murali; Jeffrey Ou; Bradford C Powell; Heidi L Rehm; Bradley Rolf; Tamara S Roman; Jessica Van Ziffle; Saurav Guha; Avinash Abhyankar; David Crosslin; Eric Venner; Bo Yuan; Hana Zouk; Gail P Jarvik
Journal:  Am J Hum Genet       Date:  2020-10-26       Impact factor: 11.025

3.  Clinical Cardiovascular Genetic Counselors Take a Leading Role in Team-based Variant Classification.

Authors:  Chloe Reuter; Megan E Grove; Kate Orland; Katherine Spoonamore; Colleen Caleshu
Journal:  J Genet Couns       Date:  2017-12-12       Impact factor: 2.537

4.  ClinGen Variant Curation Expert Panel experiences and standardized processes for disease and gene-level specification of the ACMG/AMP guidelines for sequence variant interpretation.

Authors:  Edgar A Rivera-Muñoz; Laura V Milko; Steven M Harrison; Danielle R Azzariti; C Lisa Kurtz; Kristy Lee; Jessica L Mester; Meredith A Weaver; Erin Currey; William Craigen; Charis Eng; Birgit Funke; Madhuri Hegde; Ray E Hershberger; Rong Mao; Robert D Steiner; Lisa M Vincent; Christa L Martin; Sharon E Plon; Erin Ramos; Heidi L Rehm; Michael Watson; Jonathan S Berg
Journal:  Hum Mutat       Date:  2018-11       Impact factor: 4.878

5.  Scaling resolution of variant classification differences in ClinVar between 41 clinical laboratories through an outlier approach.

Authors:  Steven M Harrison; Jill S Dolinksy; Wenjie Chen; Christin D Collins; Soma Das; Joshua L Deignan; Kathryn B Garber; John Garcia; Olga Jarinova; Amy E Knight Johnson; Juha W Koskenvuo; Hane Lee; Rong Mao; Rebecca Mar-Heyming; Andrew S McFaddin; Krista Moyer; Narasimhan Nagan; Stefan Rentas; Avni B Santani; Eija H Seppälä; Brian H Shirts; Timothy Tidwell; Scott Topper; Lisa M Vincent; Kathy Vinette; Heidi L Rehm
Journal:  Hum Mutat       Date:  2018-11       Impact factor: 4.878

6.  2020 APHRS/HRS expert consensus statement on the investigation of decedents with sudden unexplained death and patients with sudden cardiac arrest, and of their families.

Authors:  Martin K Stiles; Arthur A M Wilde; Dominic J Abrams; Michael J Ackerman; Christine M Albert; Elijah R Behr; Sumeet S Chugh; Martina C Cornel; Karen Gardner; Jodie Ingles; Cynthia A James; Jyh-Ming Jimmy Juang; Stefan Kääb; Elizabeth S Kaufman; Andrew D Krahn; Steven A Lubitz; Heather MacLeod; Carlos A Morillo; Koonlawee Nademanee; Vincent Probst; Elizabeth V Saarel; Luciana Sacilotto; Christopher Semsarian; Mary N Sheppard; Wataru Shimizu; Jonathan R Skinner; Jacob Tfelt-Hansen; Dao Wu Wang
Journal:  Heart Rhythm       Date:  2020-10-19       Impact factor: 6.343

7.  2020 APHRS/HRS expert consensus statement on the investigation of decedents with sudden unexplained death and patients with sudden cardiac arrest, and of their families.

Authors:  Martin K Stiles; Arthur A M Wilde; Dominic J Abrams; Michael J Ackerman; Christine M Albert; Elijah R Behr; Sumeet S Chugh; Martina C Cornel; Karen Gardner; Jodie Ingles; Cynthia A James; Jyh-Ming Jimmy Juang; Stefan Kääb; Elizabeth S Kaufman; Andrew D Krahn; Steven A Lubitz; Heather MacLeod; Carlos A Morillo; Koonlawee Nademanee; Vincent Probst; Elizabeth V Saarel; Luciana Sacilotto; Christopher Semsarian; Mary N Sheppard; Wataru Shimizu; Jonathan R Skinner; Jacob Tfelt-Hansen; Dao Wu Wang
Journal:  J Arrhythm       Date:  2021-04-08

8.  Clinical characteristics and outcomes in childhood-onset hypertrophic cardiomyopathy.

Authors:  Nicholas A Marston; Larry Han; Iacopo Olivotto; Sharlene M Day; Euan A Ashley; Michelle Michels; Alexandre C Pereira; Jodie Ingles; Christopher Semsarian; Daniel Jacoby; Steven D Colan; Joseph W Rossano; Samuel G Wittekind; James S Ware; Sara Saberi; Adam S Helms; Carolyn Y Ho
Journal:  Eur Heart J       Date:  2021-05-21       Impact factor: 29.983

9.  Clinically impactful differences in variant interpretation between clinicians and testing laboratories: a single-center experience.

Authors:  Austin Bland; Elizabeth A Harrington; Kyla Dunn; Mitchel Pariani; Julia C K Platt; Megan E Grove; Colleen Caleshu
Journal:  Genet Med       Date:  2017-12-14       Impact factor: 8.822

10.  MAGUS: A Shared Tool for the Genetic Community.

Authors:  Jessica R Golbus; Brahmajee K Nallamothu; Rahul C Deo
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2018-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.